Global Veterinary Cardiology Market to Demonstrate Long-Term Growth Potential Through 2026–2035

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Aripiprazole Market Projected To Become By 2030 Based On Its 2026 Valuation?

The veterinary cardiology market size has experienced strong growth in recent years. It is projected to expand from $3.1 billion in 2025 to $3.38 billion in 2026, at a compound annual growth rate (CAGR) of 9.1%. This historical growth can be linked to an increased prevalence of congenital heart defects in pets, rising awareness about pet healthcare, a growing number of veterinary hospitals and clinics, advancements in diagnostic imaging technologies, and the adoption of conventional pharmaceuticals for cardiac diseases.

The veterinary cardiology market is projected to witness significant growth in the coming years, expanding to $4.73 billion in 2030 with a compound annual growth rate (CAGR) of 8.7%. This anticipated growth during the forecast period is driven by factors such as the increasing adoption of telemedicine in veterinary cardiology, a rise in pet insurance coverage, the development of AI-enabled diagnostic tools, an enhanced focus on preventive and personalized cardiac care, and the expanding companion animal population in urban regions. Key trends for this period encompass telecardiology and remote cardiac monitoring, the use of minimally invasive cardiac procedures, personalized treatment plans for companion animals, advanced cardiac imaging techniques, and the integration of nutraceuticals for preventive cardiac care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20681&type=smp

What Primary Drivers Are Shaping The Development Of The Aripiprazole Market?

The expanding occurrences of heart diseases in pets and livestock are projected to boost the growth of the veterinary cardiology market moving forward. These conditions in animals refer to medical issues affecting the heart’s structure and function, leading to impaired blood circulation, reduced cardiac efficiency, and potential broader health complications. The surge in heart disease cases in pets and livestock stems from factors like extended lifespans, obesity, poor dietary habits, genetic predispositions, and insufficient regular veterinary care. Moreover, environmental stressors and alterations in living conditions can contribute to the prevalence of cardiovascular conditions in these animals. Veterinary cardiology aids in the diagnosis, treatment, and management of heart diseases in pets and livestock by offering specialized care, advanced imaging, and innovative procedures such as minimally invasive surgeries to enhance heart health and overall quality of life. For example, in March 2024, the American Veterinary Medical Association, a US-based not-for-profit organization, reported that Myxomatous mitral valve degeneration (MMVD) is the most common heart disease in dogs in North America, constituting 75% of all canine cardiac conditions. It is noted that 85% of small dogs aged 13 years exhibit signs of a myxomatous mitral valve lesion, although this presence does not always carry clinical significance. For dogs with MMVD, the estimated rate of cardiac-related deaths falls between 40% and 70%. Thus, the growing incidence of heart diseases in pets and livestock will propel the expansion of the veterinary cardiology market.

What Segment Groups Are Identified Within The Aripiprazole Market?

The veterinary cardiology market covered in this report is segmented –

1) By Product: Pharmaceuticals, Diagnostics

2) By Indication: Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Other Indications

3) By Animal Type: Companion Animals, Production Animals

4) By End-User: Veterinary Hospitals, Clinics, Other End Users

Subsegments:

1) By Pharmaceuticals: Antihypertensives, Diuretics, Antiarrhythmic Drugs, Beta Blockers, ACE Inhibitors, Calcium Channel Blockers, Positive Inotropes, Nutraceuticals For Cardiac Health

2) By Diagnostics: Electrocardiograms (ECG), Echocardiography Devices, Holter Monitors, Blood Pressure Monitors, Cardiac Biomarker Tests, Thoracic Radiography, Ultrasound Devices, Telemedicine Solutions for Cardiac Monitoring

What Trends Are Advancing Progress In The Veterinary Cardiology Market?

Major entities within the veterinary cardiology market are advancing technologically, introducing innovations like transcatheter edge-to-edge mitral valve repair (TEER) to enhance the treatment of cardiac conditions in animals, improve surgical outcomes, and provide minimally invasive alternatives for better patient recovery and overall quality of life. Transcatheter edge-to-edge mitral valve repair (TEER) is a less intrusive cardiac procedure engineered to remedy mitral valve leakage by utilizing a clamp to optimize valve function and alleviate heart strain. As an illustration, in February 2023, Willows Veterinary Centre, a UK-based veterinary referral facility, initiated a pioneering heart therapy for dogs aimed at treating myxomatous mitral valve disease (MMVD), which stands as the most common heart ailment in canines. This treatment is now considered a viable substitute for surgical interventions in human patients, with early clinical data from dogs showing considerable promise. The process is carried out under general anesthesia through a small incision in the chest wall. A needle is inserted at the heart’s apex, with exact direction ensured by continuous X-rays and transesophageal ultrasound. This approach allows for the accurate placement of a V-clamp across the mitral valve to effectively reduce leakage.

Which Companies Hold Significant Positions In The Aripiprazole Market?

Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Santé Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet

Read the full veterinary cardiology market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-cardiology-global-market-report

How Does The Aripiprazole Market Perform Across Major Global Regions?

North America was the largest region in the veterinary cardiology market in 2025. The regions covered in the veterinary cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Aripiprazole Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20681&type=smp

Browse Through More Reports Similar to the Global Veterinary Cardiology Market 2026, By The Business Research Company

Veterinary Pain Management Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

Veterinary Reference Laboratory Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-reference-laboratory-global-market-report

Veterinary Stereotactic Radiosurgery System Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-stereotactic-radiosurgery-system-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795